Serial/Series Title
10 Matching Results
Results open in a new window/tab.
Results:
1 - 10 of
10
Birth Outcomes Following Zidovudine Therapy in Pregnant Women
A published article by Morbidity and Mortality about the birth outcomes after treating HIV positive pregnant women with zidovudine (ZDV).
Date:
June 10, 1994
Creator:
Massachusetts Medical Society
System:
The UNT Digital Library
[Press Release: AZT Reduces Rate of Maternal Transmission of HIV]
A press release from the National Institute of Allergy and Infectious Disease discussing how AZT therapy reduces the transmission of HIV from infected mothers to their babies during child birth.
Date:
February 21, 1994
Creator:
National Institute of Allergy and Infectious Disease
System:
The UNT Digital Library
[News Release: Retrovir Indicated to Prevent Transmission of HIV from Pregnant Women to Their Babies]
A news release from Burrough Wellcome Co. announcing that the U.S. Food and Drug Administration released Retrovir (AZT) for therapy to prevent the transmission of HIV from infected mothers to their babies.
Date:
August 9, 1994
Creator:
Burrough Wellcome Co.
System:
The UNT Digital Library
Racial Differences in the Use of Drug Therapy for HIV Disease in an Urban Community
An article published by the NEJM exploring the sociodemographic differences in prophylactic therapy of HIV infected individuals.
Date:
February 16, 1994
Creator:
NEJM
System:
The UNT Digital Library
ATIN: AIDS TARGETED INFORMATION
A document discussing the effectiveness of AZT, a drug designed to slow the progression of HIV to AIDS.
Date:
February 1993
Creator:
unknown
System:
The UNT Digital Library
Long-Term Follow-Up of Zidovudine Therapy in Asymptomatic HIV Infection: Results of Multicenter Cohort Study
Research published in the Journal of Acquired Immune Deficiency Syndromes that explained that zidovudine (AZT) is only beneficial to people with HIV/AIDS within the first year of treatment and that after three years there were no sustained clinical benefit.
Date:
1994
Creator:
Journal of Acquired Immune Deficiency Syndromes
System:
The UNT Digital Library
[News Release: "Quality of Life" in Patients Receiving Retrovir]
A document discussing the use of zidovudine (AZT) as a way of slowing HIV's progression to AIDS and how AZT may impact the patients' quality of life.
Date:
February 17, 1994
Creator:
Burroughs Wellcome Co.
System:
The UNT Digital Library
[Informational Document: Retrovir Fact File]
An informational document from Burroughs Wellcome Co. providing health and medical reporters with additional information about Retrovir.
Date:
July 22, 1994
Creator:
Burrough Wellcome Co.
System:
The UNT Digital Library
[News Release: Italian Study Supports Clinical Benefit to Early Therapy With AZT]
A news release from Burroughs Wellcome Co. explaining that an Italian study verified the clinical benefits of Burrough Wellcome's brand of zidovudine (AZT) as being helpful in preventing the onset of AIDS in HIV infected individuals.
Date:
March 1994
Creator:
Burroughs Wellcome Co.
System:
The UNT Digital Library
[News Release: Italian Study Supports Clinical Benefit to Early Therapy with AZT]
A news release from Burrough Wellcome Co. about the clinical benefits of their brand of zidovudine (AZT), Retrovir, in slowing the progression of HIV to AIDS.
Date:
March 1994
Creator:
Burrough Wellcome Co.
System:
The UNT Digital Library